Search｜Photos & Images & Videos｜KYODO NEWS IMAGES INC

Yearender: Xinhua's top 10 world news events in 2022

(221230) -- BEIJING, Dec. 30, 2022 (Xinhua) -- This photo taken on Aug. 31, 2022 shows the production line of COVID-19 vaccine under the Butantan Institute in the state of Sao Paulo, Brazil. Since June 2020, Chinese biopharmaceutical company Sinovac has carried out cooperation with the Butantan Institute to conduct a number of clinical studies, the most important of which is the Phase III clinical trial of the COVID-19 vaccine. Xinhua's top 10 world news events in 2022 Persistent COVID-19 pandemic profoundly shapes world The persistent COVID-19 pandemic has caused tremendous damage to people's lives and health, had a profound impact on the world economy and people's work and life, and exacerbated supply chain disruptions and labor shortages. Putting people and their lives first, the Chinese government has been optimizing its response measures, and has achieved major positive results in coordinating epidemic prevention and control with socioeconomic development. Countries worldwide should focus o

E

Proton therapy clinical trial for breast cancer to begin

FUKUI, Japan - Kazutaka Yamamoto, head of the Proton Therapy Center at the Fukui Prefectural Hospital, displays a brassiere designed for treatment of women with breast cancer and other equipment in Fukui city, Japan, on Oct. 24, 2014. The center will begin the first clinical trial on the use of protons for treatment of breast cancer in Japan.

E

Researcher Moriguchi returns to Japan

TOKYO, Japan - Researcher Hisashi Moriguchi (C) meets the press at JR Tokyo Station on Oct. 15, 2012, after returning to Japan from the United States. The same day, the Japanese government and universities began looking into research projects involving Moriguchi, who falsely claimed he had implemented the world's first clinical trial using a trailblazing stem cell technology.

E

Researcher Moriguchi returns to Japan

NARITA, Japan - Researcher Hisashi Moriguchi (C) is surrounded by police and journalists at Narita airport, near Tokyo, on Oct. 15, 2012, after arriving on a flight from the United States. The same day, the Japanese government and universities began looking into research projects involving Moriguchi, who falsely claimed he had implemented the world's first clinical trial using a trailblazing stem cell technology.

E

Researcher Moriguchi returns to Japan

NARITA, Japan - Researcher Hisashi Moriguchi meets the press at Narita airport, near Tokyo, on Oct. 15, 2012, after arriving from the United States. The same day, the Japanese government and universities began looking into research projects involving Moriguchi, who falsely claimed he had implemented the world's first clinical trial using a trailblazing stem cell technology.

E

Researcher Moriguchi returns to Japan

NARITA, Japan - Researcher Hisashi Moriguchi (C) is surrounded by police and journalists at Narita airport, near Tokyo, on Oct. 15, 2012, after arriving on a flight from the United States. The same day, the Japanese government and universities began looking into research projects involving Moriguchi, who falsely claimed he had implemented the world's first clinical trial using a trailblazing stem cell technology.

E

Researcher Moriguchi returns to Japan

NARITA, Japan - Researcher Hisashi Moriguchi arrives at Narita airport, near Tokyo, on Oct. 15, 2012, from the United States. The same day, the Japanese government and universities began looking into research projects involving Moriguchi, who falsely claimed he had implemented the world's first clinical trial using a trailblazing stem cell technology.

E

Researcher Moriguchi returns to Japan

NARITA, Japan - Researcher Hisashi Moriguchi (C) is surrounded by police and journalists at Narita airport, near Tokyo, on Oct. 15, 2012, after arriving on a flight from the United States. The same day, the Japanese government and universities began looking into research projects involving Moriguchi, who falsely claimed he had implemented the world's first clinical trial using a trailblazing stem cell technology.

E

Researcher Moriguchi returns to Japan

NARITA, Japan - Researcher Hisashi Moriguchi meets the press at Narita airport, near Tokyo, on Oct. 15, 2012, after arriving from the United States. The same day, the Japanese government and universities began looking into research projects involving Moriguchi, who falsely claimed he had implemented the world's first clinical trial using a trailblazing stem cell technology.

E

Researcher Moriguchi returns to Japan

NARITA, Japan - Researcher Hisashi Moriguchi meets the press at Narita airport, near Tokyo, on Oct. 15, 2012, after arriving from the United States. The same day, the Japanese government and universities began looking into research projects involving Moriguchi, who falsely claimed he had implemented the world's first clinical trial using a trailblazing stem cell technology.

E

Explore medical 3D printing center in C China

STORY: Explore medical 3D printing center in C China DATELINE: Dec. 2, 2022 LENGTH: 00:01:19 LOCATION: ZHENGZHOU, China CATEGORY: TECHNOLOGY/HEALTH SHOTLIST: 1. various of 3D printed models 2. SOUNDBITE 1 (Chinese): WANG YIFAN, Assistant engineer of Medical 3D Printing Center of the First Affiliated Hospital of Zhengzhou University 3. various of 3D printed models 4. SOUNDBITE 2 (Chinese): WANG YIFAN, Assistant engineer of Medical 3D Printing Center of the First Affiliated Hospital of Zhengzhou University STORYLINE: A medical 3D printing center in central China's Henan Province has been working on clinical application and scientific research of 3D printing technology, combined with the application of digital imaging and precision medicine. An expert from the center says the 3D printed models can serve as convenient tools to trial the placement of implants and other medical devices. SOUNDBITE 1 (Chinese): WANG YIFAN, Assistant engineer of Medical 3D Printing Center of the First Affiliated Hospital of Zheng

E

Chinese study provides evidence for improved stroke treatment

STORY: Chinese study provides evidence for improved stroke treatment DATELINE: Oct. 29, 2022 LENGTH: 00:02:13 LOCATION: HEFEI, China CATEGORY: HEALTH SHOTLIST: 1. various of doctors and medical staff working at hospitals 2. SOUNDBITE 1 (Chinese): HU WEI, Neurologist, The First Affiliated Hospital of the University of Science and Technology of China 3. SOUNDBITE 2 (English): ADNAN QURESHI, Professor of clinical neurology, University of Missouri School of Medicine STORYLINE: Saturday marks the annual World Stroke Day. Clinicians have found in a new study that removing blood clots within 12 hours after the onset of a stroke can noticeably improve patients' health and reduce death rates. The findings by a Chinese team were reported in the New England Journal of Medicine on Oct. 13. The efforts were led by researchers from the First Affiliated Hospital of the University of Science and Technology of China. They conducted a randomized, controlled trial involving 340 patients with an average age of 66.5 at 36

E

Gifu Univ. develops dog food with cancer preventing ingredients

Gifu University unveils samples of the world's first dog food containing extracts of plants regarded as effective in cancer prevention, on Aug. 19, 2015, in Gifu, central Japan. The university, aiming at commercializing the product in three years' time, will begin a clinical trial from September. (Kyodo) ==Kyodo

E

Clinical trial eyed on candidate drug against prion disease

Prof. Kazuo Kuwata of the United Graduate School of Drug Discovery and Medical Information Sciences of Gifu University shows off a facility for testing a candidate drug against prion disease in Gifu, central Japan, on Feb. 13, 2015. His R&D team will begin a clinical trial on the drug, which the university claims will be the first such study in the world, probably in January 2017. (Kyodo) ==Kyodo

E

Proton therapy clinical trial for breast cancer to begin

FUKUI, Japan - Kazutaka Yamamoto, head of the Proton Therapy Center at the Fukui Prefectural Hospital, displays a brassiere designed for treatment of women with breast cancer and other equipment in Fukui city, Japan, on Oct. 24, 2014. The center will begin the first clinical trial on the use of protons for treatment of breast cancer in Japan. (Kyodo)

E

World's 1st trial of drug developed from iPS cells to begin

Junya Toguchida, professor at Kyoto University, speaks at a press conference in Kyoto on Aug. 1, 2017, announcing that his team will begin the world's first clinical trial of a drug developed from induced pluripotent stem cells to treat fibrodysplasia ossificans progressiva, a rare bone disease. (Kyodo) ==Kyodo